Trial
NCT02298153
A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Incyte Corporation
Collaborators
Hoffmann-La Roche; Genentech, Inc.
Condition
NSCLC (Non-small Cell Lung Carcinoma)
Intervention
Epacadostat
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-20